|
⚲
|
| Tobira Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001409690 |
| Sale | 2010-03-04 ($4.0 M Offered, $4.0 M Sold) |
| Fund | |
| Phone | 6098971102 |
| Address | 214 Carnegie Center, Suite 306 Princeton, 08540 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Kathleen McGowan | |
| Carol Brosgart | |
| Daniel Turner | |
| Laurent Fischer | |
| Brian Halak | |
| Patrick Heron | |
| Michael Kamdar | |
| James Sapirstein | |
| Eckard Weber |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
WV AIV II Ppt-2 LLC
✚
|
0.0 | |
|
WV Feeder III (ALKU), L.P.
✚
|
0.0 | |
|
WV Feeder II (PPT-2), L.P.
✚
|
0.0 | |
|
WWA Group Inc
✚
|
0.0 | |
|
xendit Inc
✚
|
0.0 | |
|
XOOM Corp
✚
|
0.0 | |
|
New Ground Capital Fund, L.P.
✚
|
0.0 | |
|
New Ground Capital Offshore Fund, Ltd.
✚
|
0.0 | |
|
New Highland Glen, L.P.
✚
|
0.0 | |
|
WV AIV III ALKU LLC
✚
|
0.0 |